Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Muirhead

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 2, 2004
Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survivalKevin McLaughlin, Sabrina Sandhu, Caren Wu, et al.
Transplantation|October 5, 2002
Cytomegalovirus seromismatching increases the risk of acute renal allograft rejectionKevin McLaughlin, Caren Wu, Gordon Fick, et al.
Therapeutic Drug Monitoring|December 25, 2013
Similar MPA exposure on modified release and regular tacrolimusGuido Filler, Alexander A Vinks, Shih-Han S Huang, et al.
Journal of the American Society of Nephrology : JASN|February 13, 2009
Supramaximal dose of candesartan in proteinuric renal diseaseEllen Burgess, Norman Muirhead, Paul Rene de Cotret, et al.
Social Work in Health Care|June 17, 2008
Living kidney donors' experiences with the health care systemJudith Belle Brown, Mary Lou Karley, Neil Boudville, et al.
Health & Social Work|May 31, 2008
The experience of living kidney donorsJudith Belle Brown, Mary Lou Karley, Neil Boudville, et al.
Clinical Transplantation|December 22, 2017
Randomized open-label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas-kidney patientsMark Cattral, Sean Luke, Michael J Knauer, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 6, 2019
Using dalteparin in quotidian and nocturnal hemodialysis patients: A prospective studyShih-Han S Huang, Karen Qi, Martha Louzada, et al.
Clinical Therapeutics|September 11, 2007
Cost-effectiveness of irbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal disease: a Canadian perspectiveDouglas Coyle, Roger Rodby, Steven Soroka, et al.
Clinical Transplantation|July 25, 2007
Apparent low absorbers of cyclosporine microemulsion have higher requirements for tacrolimus in renal transplantationAndrew A House, Mostafa Elmestiri, Kathy Denesyk, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 2, 2004
Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survivalKevin McLaughlin, Sabrina Sandhu, Caren Wu, et al.
Transplantation|October 5, 2002
Cytomegalovirus seromismatching increases the risk of acute renal allograft rejectionKevin McLaughlin, Caren Wu, Gordon Fick, et al.
Therapeutic Drug Monitoring|December 25, 2013
Similar MPA exposure on modified release and regular tacrolimusGuido Filler, Alexander A Vinks, Shih-Han S Huang, et al.
Journal of the American Society of Nephrology : JASN|February 13, 2009
Supramaximal dose of candesartan in proteinuric renal diseaseEllen Burgess, Norman Muirhead, Paul Rene de Cotret, et al.
Social Work in Health Care|June 17, 2008
Living kidney donors' experiences with the health care systemJudith Belle Brown, Mary Lou Karley, Neil Boudville, et al.
Health & Social Work|May 31, 2008
The experience of living kidney donorsJudith Belle Brown, Mary Lou Karley, Neil Boudville, et al.
Clinical Transplantation|December 22, 2017
Randomized open-label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas-kidney patientsMark Cattral, Sean Luke, Michael J Knauer, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 6, 2019
Using dalteparin in quotidian and nocturnal hemodialysis patients: A prospective studyShih-Han S Huang, Karen Qi, Martha Louzada, et al.
Clinical Therapeutics|September 11, 2007
Cost-effectiveness of irbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal disease: a Canadian perspectiveDouglas Coyle, Roger Rodby, Steven Soroka, et al.
Clinical Transplantation|July 25, 2007
Apparent low absorbers of cyclosporine microemulsion have higher requirements for tacrolimus in renal transplantationAndrew A House, Mostafa Elmestiri, Kathy Denesyk, et al.
Pageof 5